Browsing Tag
Phase 2 clinical trial
5 posts
SGX945 demonstrates lasting oral ulcer reduction in Phase 2 Behçet’s disease trial
Find out how SGX945 achieved durable oral ulcer reduction in a phase 2 Behçet’s disease trial published in Rheumatology (Oxford).
Neuren Pharmaceuticals achieves breakthrough in Pitt Hopkins syndrome treatment
Neuren Pharmaceuticals (ASX: NEU) has announced promising top-line results from its Phase 2 clinical trial of NNZ-2591, aimed…
Rezolute’s Phase 2 trial of RZ402 shows significant CST reduction in DME patients
Rezolute, Inc. (Nasdaq: RZLT), a leader in the development of novel therapies for serious metabolic and rare diseases,…
EyePoint Pharmaceuticals reports mixed results for DURAVYU in Phase 2 diabetic retinopathy trial
EyePoint Pharmaceuticals, Inc., committed to innovative therapeutics for serious retinal diseases, today disclosed the top-line results of the…
OncoSec Medical begins phase 2 trial for TAVO and OPDIVO combination in melanoma treatment
OncoSec Medical, a US-based biotechnology company, has officially dosed the first patient in its phase 2 clinical trial,…